ZA964441B - Isothiazolones - Google Patents
IsothiazolonesInfo
- Publication number
- ZA964441B ZA964441B ZA964441A ZA964441A ZA964441B ZA 964441 B ZA964441 B ZA 964441B ZA 964441 A ZA964441 A ZA 964441A ZA 964441 A ZA964441 A ZA 964441A ZA 964441 B ZA964441 B ZA 964441B
- Authority
- ZA
- South Africa
- Prior art keywords
- isothiazolones
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
- C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
- C07D513/14—Ortho-condensed systems
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/456,149 US5620997A (en) | 1995-05-31 | 1995-05-31 | Isothiazolones |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA964441B true ZA964441B (en) | 1996-12-10 |
Family
ID=23811632
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA964441A ZA964441B (en) | 1995-05-31 | 1996-05-30 | Isothiazolones |
Country Status (37)
| Country | Link |
|---|---|
| US (4) | US5620997A (es) |
| EP (1) | EP0828488B1 (es) |
| JP (1) | JP2002502353A (es) |
| KR (2) | KR20040004547A (es) |
| CN (1) | CN1114402C (es) |
| AR (1) | AR002740A1 (es) |
| AT (1) | ATE232385T1 (es) |
| AU (1) | AU723233B2 (es) |
| BG (1) | BG62792B1 (es) |
| CA (1) | CA2218253A1 (es) |
| CO (1) | CO4700292A1 (es) |
| CZ (1) | CZ373997A3 (es) |
| DE (1) | DE69626203T2 (es) |
| DK (1) | DK0828488T3 (es) |
| EA (1) | EA000898B1 (es) |
| EE (1) | EE9700287A (es) |
| ES (1) | ES2192224T3 (es) |
| GE (1) | GEP20012375B (es) |
| GT (1) | GT199600026A (es) |
| HN (1) | HN1996000017A (es) |
| HR (1) | HRP960216B1 (es) |
| HU (1) | HUP9900917A3 (es) |
| IL (1) | IL117859A (es) |
| MX (1) | MX9707948A (es) |
| MY (1) | MY118452A (es) |
| NO (1) | NO975496L (es) |
| NZ (1) | NZ307023A (es) |
| OA (1) | OA10745A (es) |
| PE (1) | PE55097A1 (es) |
| PL (1) | PL323683A1 (es) |
| PT (1) | PT828488E (es) |
| SK (1) | SK162297A3 (es) |
| SV (2) | SV1996000026A (es) |
| TW (1) | TW418206B (es) |
| UY (1) | UY24244A1 (es) |
| WO (1) | WO1996038144A1 (es) |
| ZA (1) | ZA964441B (es) |
Families Citing this family (107)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6001863A (en) * | 1996-11-26 | 1999-12-14 | Warner-Lambert Company | Isothiazolones |
| ATE336483T1 (de) * | 1998-06-19 | 2006-09-15 | Us Health | Thiolester und ihre anwendungen |
| US6706729B1 (en) | 1998-06-19 | 2004-03-16 | The United States Of America As Represented By The Department Of Health And Human Services | Thiolesters and uses thereof |
| GEP20033045B (en) | 1998-09-17 | 2003-08-25 | Bristol Myers Squibb Co | Method for Treating Diabetes |
| GB9917408D0 (en) | 1999-07-23 | 1999-09-22 | Smithkline Beecham Plc | Compounds |
| GB9917406D0 (en) | 1999-07-23 | 1999-09-22 | Smithkline Beecham Plc | Compounds |
| TW591031B (en) * | 2000-02-29 | 2004-06-11 | Takeda Chemical Industries Ltd | Thienopyridine derivatives, their production and use |
| US6395767B2 (en) | 2000-03-10 | 2002-05-28 | Bristol-Myers Squibb Company | Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method |
| US6432433B1 (en) | 2000-06-05 | 2002-08-13 | Isp Investments Inc. | Liquid biocidal composition of a formaldehyde adduct and an isothiazolone and method of use |
| CN1452619A (zh) | 2000-07-26 | 2003-10-29 | 史密斯克莱·比奇曼公司 | 具有抗细菌活性的氨基哌啶喹啉和它们的氮杂等排的类似物 |
| GB0101577D0 (en) | 2001-01-22 | 2001-03-07 | Smithkline Beecham Plc | Compounds |
| DE60209343T2 (de) | 2001-04-11 | 2006-10-26 | Bristol-Myers Squibb Co. | Aminosäurekomplexe von c-arylglycosiden zur behandlung von diabetes und verfahren |
| US7238671B2 (en) | 2001-10-18 | 2007-07-03 | Bristol-Myers Squibb Company | Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions |
| JP2005514337A (ja) | 2001-10-18 | 2005-05-19 | ブリストル−マイヤーズ スクイブ カンパニー | ヒトグルカゴン様ペプチド−１模倣体、並びに糖尿病および関連疾患の処置におけるその使用 |
| AU2002348276A1 (en) | 2001-11-16 | 2003-06-10 | Bristol-Myers Squibb Company | Dual inhibitors of adipocyte fatty acid binding protein and keratinocyte fatty acid binding protein |
| WO2003055448A2 (en) * | 2001-12-21 | 2003-07-10 | Achillion Pharmaceuticals, Inc. | Antifungal compositions |
| US7101676B2 (en) * | 2002-01-11 | 2006-09-05 | Douglas Buechter | Methods for identifying compounds which inhibit binding of nucleocapsid 7 protein to HIV-1 RNA |
| EP2181996A1 (en) | 2002-01-29 | 2010-05-05 | Glaxo Group Limited | Aminopiperidine derivatives |
| CN1936023A (zh) * | 2002-02-08 | 2007-03-28 | 霍夫曼-拉罗奇有限公司 | 治疗和预防骨损失的方法 |
| GB0208223D0 (en) * | 2002-04-10 | 2002-05-22 | Celltech R&D Ltd | Chemical compounds |
| US7057046B2 (en) | 2002-05-20 | 2006-06-06 | Bristol-Myers Squibb Company | Lactam glycogen phosphorylase inhibitors and method of use |
| WO2004037181A2 (en) | 2002-10-23 | 2004-05-06 | Bristol-Myers Squibb Company | Glycinenitrile-based inhibitors of dipeptidyl peptidase iv and methods |
| US7098235B2 (en) | 2002-11-14 | 2006-08-29 | Bristol-Myers Squibb Co. | Triglyceride and triglyceride-like prodrugs of glycogen phosphorylase inhibiting compounds |
| TW200504021A (en) | 2003-01-24 | 2005-02-01 | Bristol Myers Squibb Co | Substituted anilide ligands for the thyroid receptor |
| US7459474B2 (en) | 2003-06-11 | 2008-12-02 | Bristol-Myers Squibb Company | Modulators of the glucocorticoid receptor and method |
| US6995183B2 (en) | 2003-08-01 | 2006-02-07 | Bristol Myers Squibb Company | Adamantylglycine-based inhibitors of dipeptidyl peptidase IV and methods |
| US7371759B2 (en) | 2003-09-25 | 2008-05-13 | Bristol-Myers Squibb Company | HMG-CoA reductase inhibitors and method |
| KR20070054762A (ko) | 2003-11-12 | 2007-05-29 | 페노믹스 코포레이션 | 헤테로시클릭 보론산 화합물 |
| US7420059B2 (en) | 2003-11-20 | 2008-09-02 | Bristol-Myers Squibb Company | HMG-CoA reductase inhibitors and method |
| RU2361862C2 (ru) * | 2003-12-29 | 2009-07-20 | Сепракор Инк. | Пиррольные и пиразольные ингибиторы daao |
| US7166725B2 (en) * | 2003-12-29 | 2007-01-23 | Sepracor Inc. | Benzo[d]isoxazol-3-ol DAAO inhibitors |
| TW200611704A (en) | 2004-07-02 | 2006-04-16 | Bristol Myers Squibb Co | Human glucagon-like-peptide-1 modulators and their use in the treatment of diabetes and related conditions |
| US7534763B2 (en) | 2004-07-02 | 2009-05-19 | Bristol-Myers Squibb Company | Sustained release GLP-1 receptor modulators |
| US7145040B2 (en) | 2004-07-02 | 2006-12-05 | Bristol-Myers Squibb Co. | Process for the preparation of amino acids useful in the preparation of peptide receptor modulators |
| EP1778220A1 (en) | 2004-07-12 | 2007-05-02 | Phenomix Corporation | Constrained cyano compounds |
| AR051446A1 (es) | 2004-09-23 | 2007-01-17 | Bristol Myers Squibb Co | Glucosidos de c-arilo como inhibidores selectivos de transportadores de glucosa (sglt2) |
| US7589088B2 (en) | 2004-12-29 | 2009-09-15 | Bristol-Myers Squibb Company | Pyrimidine-based inhibitors of dipeptidyl peptidase IV and methods |
| US7635699B2 (en) | 2004-12-29 | 2009-12-22 | Bristol-Myers Squibb Company | Azolopyrimidine-based inhibitors of dipeptidyl peptidase IV and methods |
| US7317024B2 (en) | 2005-01-13 | 2008-01-08 | Bristol-Myers Squibb Co. | Heterocyclic modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof |
| EP2527337A1 (en) | 2005-04-14 | 2012-11-28 | Bristol-Myers Squibb Company | Inhibitors of 11-beta hydroxysteroid dehydrogenase type I |
| MX2007013415A (es) * | 2005-05-04 | 2008-01-15 | Hoffmann La Roche | Compuestos antivirales heterociclicos. |
| US7521557B2 (en) | 2005-05-20 | 2009-04-21 | Bristol-Myers Squibb Company | Pyrrolopyridine-based inhibitors of dipeptidyl peptidase IV and methods |
| US7888381B2 (en) | 2005-06-14 | 2011-02-15 | Bristol-Myers Squibb Company | Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity, and use thereof |
| JP2009500425A (ja) | 2005-07-06 | 2009-01-08 | セプラコア インコーポレーテッド | エスゾピクロン及びトランス４−（３，４−ジクロロフェニル）−１，２，３，４−テトラヒドロ−ｎ−メチル−１−ナフタレンアミン又はトランス４−（３，４−ジクロロフェニル）−１，２，３，４−テトラヒドロ−１−ナフタレンアミンの組み合わせ、並びに閉経期並びに気分、不安、及び認知障害の治療方法 |
| WO2007053819A2 (en) | 2005-10-31 | 2007-05-10 | Bristol-Myers Squibb Company | Pyrrolidinyl beta-amino amide-based inhibitors of dipeptidyl peptidase iv and methods |
| US7464565B2 (en) * | 2005-11-29 | 2008-12-16 | Maytag Corporation | Rapid temperature change device for a refrigerator |
| US7592461B2 (en) | 2005-12-21 | 2009-09-22 | Bristol-Myers Squibb Company | Indane modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof |
| CA2636324C (en) * | 2006-01-06 | 2012-03-20 | Sepracor Inc. | Cycloalkylamines as monoamine reuptake inhibitors |
| EP1978961B1 (en) * | 2006-01-06 | 2016-03-16 | Sunovion Pharmaceuticals Inc. | Tetralone-based monoamine reuptake inhibitors |
| PT2013835E (pt) | 2006-03-31 | 2016-01-06 | Sunovion Pharmaceuticals Inc | Preparação de amidas and aminas quirais |
| US7803778B2 (en) | 2006-05-23 | 2010-09-28 | Theracos, Inc. | Glucose transport inhibitors and methods of use |
| US20100022457A1 (en) | 2006-05-26 | 2010-01-28 | Bristol-Myers Squibb Company | Sustained release glp-1 receptor modulators |
| US7919598B2 (en) | 2006-06-28 | 2011-04-05 | Bristol-Myers Squibb Company | Crystal structures of SGLT2 inhibitors and processes for preparing same |
| US7579370B2 (en) * | 2006-06-30 | 2009-08-25 | Sepracor Inc. | Fused heterocycles |
| US7884124B2 (en) * | 2006-06-30 | 2011-02-08 | Sepracor Inc. | Fluoro-substituted inhibitors of D-amino acid oxidase |
| US7727978B2 (en) | 2006-08-24 | 2010-06-01 | Bristol-Myers Squibb Company | Cyclic 11-beta hydroxysteroid dehydrogenase type I inhibitors |
| US20080082066A1 (en) * | 2006-10-02 | 2008-04-03 | Weyerhaeuser Co. | Crosslinked carboxyalkyl cellulose fibers having non-permanent and temporary crosslinks |
| WO2008057857A1 (en) | 2006-11-01 | 2008-05-15 | Bristol-Myers Squibb Company | MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-ϰB ACTIVITY AND USE THEREOF |
| WO2008057862A2 (en) | 2006-11-01 | 2008-05-15 | Bristol-Myers Squibb Company | MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-ϰB ACTIVITY AND USE THEREOF |
| MX2009007410A (es) * | 2007-01-18 | 2009-09-09 | Sepracor Inc | Inhibidores de d-aminoacido oxidasa. |
| US7902252B2 (en) * | 2007-01-18 | 2011-03-08 | Sepracor, Inc. | Inhibitors of D-amino acid oxidase |
| AR065809A1 (es) | 2007-03-22 | 2009-07-01 | Bristol Myers Squibb Co | Formulaciones farmaceuticas que contienen un inhibidor sglt2 |
| JP2010524953A (ja) | 2007-04-17 | 2010-07-22 | ブリストル−マイヤーズ スクイブ カンパニー | 縮合ヘテロ環１１−β−ヒドロキシステロイドデヒドロゲナーゼＩ型阻害剤 |
| PE20090696A1 (es) | 2007-04-20 | 2009-06-20 | Bristol Myers Squibb Co | Formas cristalinas de saxagliptina y procesos para preparar las mismas |
| EP2144902B1 (en) | 2007-05-04 | 2012-05-16 | Bristol-Myers Squibb Company | [6,6]and [6,7]-bicyclic gpr119 g protein-coupled receptor agonists |
| JP2010526146A (ja) | 2007-05-04 | 2010-07-29 | ブリストル−マイヤーズ スクイブ カンパニー | ［６，５］−二環式ｇｐｒ１１９ｇタンパク質結合受容体アゴニスト |
| CN101687782A (zh) * | 2007-05-25 | 2010-03-31 | 沃泰克斯药物股份有限公司 | 离子通道调节剂及其使用方法 |
| JP5420534B2 (ja) | 2007-05-31 | 2014-02-19 | サノビオン ファーマシューティカルズ インク | モノアミン再取り込み阻害薬としてのフェニル置換シクロアルキルアミン |
| ES2371515T3 (es) | 2007-07-17 | 2012-01-04 | Bristol-Myers Squibb Company | Agonistas del receptor grp119 acoplado a proteína g. piridona. |
| ES2408384T3 (es) | 2007-07-27 | 2013-06-20 | Bristol-Myers Squibb Company | Nuevos activadores de glucoquinasa y procedimientos de uso de los mismos |
| SG188800A1 (en) | 2007-08-23 | 2013-04-30 | Theracos Inc | Benzylbenzene derivatives and methods of use |
| JP2011503081A (ja) | 2007-11-01 | 2011-01-27 | ブリストル−マイヤーズ スクイブ カンパニー | グルココルチコイド受容体、ＡＰ−１および／またはＮＦ−κＢ活性の調節剤として有用な非ステロイド性化合物、並びにその使用 |
| NZ585297A (en) * | 2007-11-15 | 2012-06-29 | Gilead Sciences Inc | Inhibitors of human immunodeficiency virus replication |
| WO2009062308A1 (en) * | 2007-11-16 | 2009-05-22 | Boehringer Ingelheim International Gmbh | Inhibitors of human immunodeficiency virus replication |
| WO2010009243A1 (en) | 2008-07-15 | 2010-01-21 | Theracos, Inc. | Deuterated benzylbenzene derivatives and methods of use |
| TW201006821A (en) | 2008-07-16 | 2010-02-16 | Bristol Myers Squibb Co | Pyridone and pyridazone analogues as GPR119 modulators |
| WO2010017418A1 (en) * | 2008-08-07 | 2010-02-11 | Sepracor Inc. | Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase |
| US20110034434A1 (en) * | 2009-08-07 | 2011-02-10 | Sepracor Inc. | Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase |
| RS57756B1 (sr) | 2009-11-13 | 2018-12-31 | Astrazeneca Ab | Formulacije tableta sa dva sloja |
| PT2498759T (pt) | 2009-11-13 | 2018-11-15 | Astrazeneca Uk Ltd | Formulações de comprimidos de libertação imediata |
| MX2012005425A (es) | 2009-11-13 | 2012-06-14 | Astrazeneca Uk Ltd | Formulaciones de metformina de masa reducida. |
| TWI562775B (en) | 2010-03-02 | 2016-12-21 | Lexicon Pharmaceuticals Inc | Methods of using inhibitors of sodium-glucose cotransporters 1 and 2 |
| WO2011116355A2 (en) * | 2010-03-19 | 2011-09-22 | Sanford-Burnham Medical Research Institute | Benzoisothiazolones as inhibitors of phosphomannose isomerase |
| JP2013523822A (ja) | 2010-04-08 | 2013-06-17 | ブリストル−マイヤーズ スクイブ カンパニー | Ｇｐｒ１１９修飾因子としてのピリミジニルピペリジニルオキシピリジノ類似体 |
| JP2013523894A (ja) | 2010-04-14 | 2013-06-17 | ブリストル−マイヤーズ スクイブ カンパニー | 新規グルコキナーゼアクチベーターおよびその使用方法 |
| EA201270778A1 (ru) | 2010-05-06 | 2013-04-30 | Бристол-Майерс Сквибб Компани | Бициклические гетероарильные аналоги в качестве модуляторов рецептора gpr119 |
| EP2566862B1 (en) | 2010-05-06 | 2015-09-16 | Bristol-Myers Squibb Company | Benzofuranyl analogues as gpr119 modulators |
| WO2011153712A1 (en) | 2010-06-12 | 2011-12-15 | Theracos, Inc. | Crystalline form of benzylbenzene sglt2 inhibitor |
| EP2600716A4 (en) | 2010-08-03 | 2014-02-19 | Beth Israel Hospital | METHOD AND COMPOSITIONS FOR THE TREATMENT OF METABOLISM DISEASES |
| TWI445696B (zh) * | 2010-11-29 | 2014-07-21 | Univ Nat Yang Ming | 標靶人類胸線核苷酸激酶誘導惡性腫瘤中的ｄｎａ修復毒性 |
| US9662328B2 (en) | 2010-11-29 | 2017-05-30 | National Yang-Ming University | Targeting human thymidylate kinase induces DNA repair toxicity in malignant tumor cells |
| TWI631963B (zh) | 2011-01-05 | 2018-08-11 | 雷西肯製藥股份有限公司 | 包含鈉－葡萄糖共同輸送體１與２之抑制劑的組合物與應用方法 |
| EP2850073B1 (en) | 2012-05-16 | 2017-07-19 | Bristol-Myers Squibb Company | Pyrimidinylpiperidinyloxypyridone analogues as gpr119 modulators |
| CA2891773C (en) | 2012-11-20 | 2021-01-19 | Lexicon Pharmaceuticals, Inc. | Inhibitors of sodium glucose cotransporter 1 |
| CN103232842B (zh) * | 2013-04-15 | 2015-11-18 | 山东大学 | 一种基于聚集诱导荧光增强材料的亚硫酸氢根离子的荧光探针及快速检验试纸 |
| US9593113B2 (en) | 2013-08-22 | 2017-03-14 | Bristol-Myers Squibb Company | Imide and acylurea derivatives as modulators of the glucocorticoid receptor |
| WO2015061272A1 (en) | 2013-10-22 | 2015-04-30 | Bristol-Myers Squibb Company | Isotopically labeled triazolopyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors |
| US20160046651A1 (en) * | 2014-07-22 | 2016-02-18 | Washington University | Treatment of malaria using inhibitors of the ispd enzyme in the non-mevalonate pathway |
| CN104230839A (zh) * | 2014-09-25 | 2014-12-24 | 上海化学试剂研究所有限公司 | 一种n-取代苯并异噻唑啉酮衍生物的合成方法 |
| US9925190B2 (en) * | 2015-02-16 | 2018-03-27 | University of Pittsburgh—of the Commonwealth System of Higher Education | Small molecules targeting HIV-1 Nef |
| SG11201708323SA (en) | 2015-04-30 | 2017-11-29 | Harvard College | Anti-ap2 antibodies and antigen binding agents to treat metabolic disorders |
| JP7072557B2 (ja) | 2016-07-22 | 2022-05-20 | ブリストル－マイヤーズ スクイブ カンパニー | グルコキナーゼ活性化剤およびその使用方法 |
| WO2019119673A1 (zh) | 2017-12-19 | 2019-06-27 | 北京吉源生物科技有限公司 | 一种双基因修饰的干细胞及其用途 |
| WO2019126567A1 (en) * | 2017-12-22 | 2019-06-27 | Southern Research Institute | Substituted heterocyclic-pyridinones as hiv-1 nef-hck inhibitors |
| US20220119333A1 (en) | 2018-08-23 | 2022-04-21 | Qingdao Wholesomtech Co., Ltd. | Phenoxy acid compounds and medical uses thereof |
| BR112021004839A2 (pt) | 2018-09-26 | 2021-06-08 | Lexicon Pharmaceuticals, Inc. | formas cristalinas de n-(1-((2-(dimetilamino)etil)amino)-2-metil-1-oxopropan-2-il)-4-(4-(2-metil-5-((2s,3r,4r,5s,6r)-3,4,5-triidróxi-6-(metiltio)tetraidro-2h-piran-2-il)benzil)fenil)butanamida e métodos de sua síntese |
| CN111253335B (zh) * | 2020-03-12 | 2023-06-06 | 浙江扬帆新材料股份有限公司 | 一种n-取代苯并异噻唑啉-3-酮衍生物的新合成方法 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE724034C (de) * | 1938-11-04 | 1942-08-17 | Algemeene Kunstvezel Mij N V | Verfahren zum Erzeugen farbiger Glasfasern |
| US3012039A (en) * | 1958-03-14 | 1961-12-05 | Ici Ltd | 2-p-chlorobenzyl-1, 2-benzisothiazolone |
| US3517022A (en) * | 1967-10-03 | 1970-06-23 | Rohm & Haas | Certain 2-carbamoyl-1,2-benzisothiazolones |
| GB1306493A (en) * | 1970-04-27 | 1973-02-14 | Sherwin Williams Co | Aromatic sulphenamides the preparation thereof and cyclization thereof |
| US3661974A (en) * | 1970-04-27 | 1972-05-09 | Sherwin Williams Co | 2-carbalkoxy-phenyl sulfenamides |
| US3761489A (en) * | 1971-12-20 | 1973-09-25 | Sherwin Williams Co | Substituted n-alkyl benzisothiazolinones |
| US4049817A (en) * | 1972-08-14 | 1977-09-20 | Sandoz Ltd. | Synergistic compositions |
| US3965107A (en) * | 1974-07-08 | 1976-06-22 | Rohm And Haas Company | Isothiazolopyridinones |
| IT1039699B (it) * | 1975-07-03 | 1979-12-10 | Prephar | Composizione spermicida a base di derivati benzisotiazolici |
| DE2602643C2 (de) * | 1976-01-24 | 1984-12-20 | Bayer Ag, 5090 Leverkusen | 1,2-Benzisothiazolinone-3, Verfahren zu ihrer Herstellung sowie Arzneimittel |
| GB1560726A (en) * | 1976-04-28 | 1980-02-06 | Beecham Group Ltd | Isothiazolo-pyridines |
| FR2492376A1 (fr) * | 1980-10-17 | 1982-04-23 | Cird | Polymethylene-4,5 isothiazoline-4 ones-3, leur procede de preparation et leurs utilisation comme agents bactericides et fongicides |
| DE3041036A1 (de) * | 1980-10-31 | 1982-06-09 | A. Nattermann & Cie GmbH, 5000 Köln | Verwendung von benzisothiazolen |
| US4458942A (en) * | 1981-12-07 | 1984-07-10 | American Seating Company | Three-quarter fold retracting chair |
| LU84091A1 (fr) * | 1982-04-16 | 1984-03-02 | Oreal | Derives n-carbamoyl d'isothiazolo-(5,4b)pyridine one-3,leur procede de preparation et leurs utilisations comme agents bactericides et fongicides |
| FR2555450B1 (fr) * | 1983-11-24 | 1988-04-01 | Oreal | Composition anti-acneique contenant en tant que compose actif un derive d'isothiazolo-(5,4b) pyridine one-3 |
| FR2631028B1 (fr) * | 1988-05-09 | 1990-07-13 | Cird | Adamantyl-2 isothiazoline-4 ones-3, leur procede de preparation et leur utilisation comme agents bactericides et fongicides |
| US5405851A (en) * | 1990-06-19 | 1995-04-11 | Burroughs Wellcome Co. | Pharmaceutical compounds |
| JPH0477476A (ja) * | 1990-07-19 | 1992-03-11 | Sankyo Co Ltd | 抗潰瘍剤 |
| US5219875A (en) * | 1990-11-27 | 1993-06-15 | Rohm And Haas Company | Antimicrobial compositions comprising iodopropargyl butylcarbamate and 1,2-benzisothiazolin-3-one and methods of controlling microbes |
| NO304832B1 (no) * | 1992-05-27 | 1999-02-22 | Ube Industries | Aminokinolonderivater samt middel mot HIV |
| FR2695378B1 (fr) * | 1992-09-10 | 1994-12-02 | Aerospatiale | Dispositif à sangle pour le maintien temporaire d'objets ensemble. |
| RU2118322C1 (ru) * | 1993-07-05 | 1998-08-27 | Дюфар Интернэшнл Рисерч Б.В. | 2,3-дигидро-1,4-бензодиокси-5-ил-пиперазиновые производные или их соли |
-
1995
- 1995-05-31 US US08/456,149 patent/US5620997A/en not_active Expired - Fee Related
- 1995-12-15 TW TW084113376A patent/TW418206B/zh not_active IP Right Cessation
- 1995-12-15 CO CO95059308A patent/CO4700292A1/es unknown
-
1996
- 1996-04-09 IL IL11785996A patent/IL117859A/xx not_active IP Right Cessation
- 1996-04-19 SV SV1996000026A patent/SV1996000026A/es unknown
- 1996-04-26 HU HU9900917A patent/HUP9900917A3/hu unknown
- 1996-04-26 DK DK96913177T patent/DK0828488T3/da active
- 1996-04-26 KR KR10-2003-7011364A patent/KR20040004547A/ko not_active Application Discontinuation
- 1996-04-26 PT PT96913177T patent/PT828488E/pt unknown
- 1996-04-26 DE DE69626203T patent/DE69626203T2/de not_active Expired - Fee Related
- 1996-04-26 CA CA002218253A patent/CA2218253A1/en not_active Abandoned
- 1996-04-26 EE EE9700287A patent/EE9700287A/xx unknown
- 1996-04-26 PL PL96323683A patent/PL323683A1/xx unknown
- 1996-04-26 AU AU55771/96A patent/AU723233B2/en not_active Ceased
- 1996-04-26 ES ES96913177T patent/ES2192224T3/es not_active Expired - Lifetime
- 1996-04-26 NZ NZ307023A patent/NZ307023A/en unknown
- 1996-04-26 CZ CZ973739A patent/CZ373997A3/cs unknown
- 1996-04-26 EP EP96913177A patent/EP0828488B1/en not_active Expired - Lifetime
- 1996-04-26 GE GEAP19964062A patent/GEP20012375B/en unknown
- 1996-04-26 KR KR1019970708611A patent/KR19990022132A/ko active IP Right Grant
- 1996-04-26 CN CN96194276A patent/CN1114402C/zh not_active Expired - Fee Related
- 1996-04-26 SK SK1622-97A patent/SK162297A3/sk unknown
- 1996-04-26 EA EA199700444A patent/EA000898B1/ru not_active IP Right Cessation
- 1996-04-26 JP JP53647396A patent/JP2002502353A/ja not_active Abandoned
- 1996-04-26 WO PCT/US1996/005821 patent/WO1996038144A1/en not_active Application Discontinuation
- 1996-04-26 AT AT96913177T patent/ATE232385T1/de not_active IP Right Cessation
- 1996-04-26 MX MX9707948A patent/MX9707948A/es not_active IP Right Cessation
- 1996-05-07 US US08/646,188 patent/US5668162A/en not_active Expired - Fee Related
- 1996-05-08 HR HR960216A patent/HRP960216B1/xx not_active IP Right Cessation
- 1996-05-15 AR ARP960102576A patent/AR002740A1/es not_active Application Discontinuation
- 1996-05-15 HN HN1996000017A patent/HN1996000017A/es unknown
- 1996-05-24 SV SV1996000033A patent/SV1996000033A/es not_active Application Discontinuation
- 1996-05-24 GT GT199600026A patent/GT199600026A/es unknown
- 1996-05-29 MY MYPI96002063A patent/MY118452A/en unknown
- 1996-05-30 PE PE1996000385A patent/PE55097A1/es not_active Application Discontinuation
- 1996-05-30 UY UY24244A patent/UY24244A1/es unknown
- 1996-05-30 ZA ZA964441A patent/ZA964441B/xx unknown
- 1996-11-26 US US08/757,716 patent/US5733921A/en not_active Expired - Fee Related
-
1997
- 1997-06-26 US US08/882,846 patent/US6133270A/en not_active Expired - Fee Related
- 1997-11-12 OA OA70126A patent/OA10745A/en unknown
- 1997-11-27 BG BG102077A patent/BG62792B1/bg unknown
- 1997-11-28 NO NO975496A patent/NO975496L/no not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP960216B1 (en) | Isothiazolones | |
| ZA965812B (en) | Azothiophenes | |
| DE59602888D1 (en) | Breitstreckaggregat | |
| DE59605001D1 (en) | Luftreinigungsgerät | |
| DE59602283D1 (en) | Inchbremseinrichtung | |
| DE59602030D1 (en) | Zellige polyurethan-elastomere | |
| DE59505396D1 (en) | Handhobelmaschine | |
| GB9525492D0 (en) | Trans-safe | |
| AP9600802A0 (en) | Libricant | |
| DE59604506D1 (en) | Rückkühlsystem | |
| DE59600830D1 (en) | Breitstrahldüse | |
| GB2322467B (en) | Twinpiano | |
| ZA964650B (en) | Mercapto-bis-triazoles | |
| DE59604913D1 (en) | Carbonylverbindungen | |
| AU1105P (en) | DALESE Metrosideros excelsus | |
| HU9500171V0 (en) | Wood- dave ment | |
| AU126163S (en) | Reveal | |
| GB9517905D0 (en) | Improved can | |
| GB9521068D0 (en) | Floodguard | |
| AU125129S (en) | Quiltcover | |
| AU127251S (en) | Sandboard | |
| AU127800S (en) | Gamesboard | |
| GB9517262D0 (en) | Firelighting | |
| GB9504568D0 (en) | Field-of-honour | |
| AU124758S (en) | Wheelcover |